- Investor's Business Daily•yesterday
Pfizer ended years of speculation that it would split into separate businesses, one focused on new drugs and the other on off-patent drugs.
New York, September 26, 2016-- Moody's Investors Service affirmed the ratings of Pfizer Inc. and related subsidiaries, including the A1 senior unsecured long-term rating and the Prime-1 commercial paper ...
Medivation, Inc. (MDVN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||81.44 x 500|
|Ask||81.48 x 1500|
|Day's Range||81.43 - 81.48|
|52wk Range||26.41 - 81.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-75.34|
|Avg Vol (3m)||4,228,500|
|Dividend & Yield||N/A (N/A)|